Neo Ivy Capital Management’s Boston Scientific BSX Stock Holding History

Neo Ivy Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,236	Closed	-$893K	–	372
2026 Q1	$893K	Buy	+14,236	New	+$1.14M	0.24%	150
2025 Q3	–	Sell	-7,392	Closed	-$794K	–	399
2025 Q2	$794K	Buy	+7,392	New	+$748K	0.25%	139
2022 Q2	–	Sell	-2,498	Closed	-$110K	–	416
2022 Q1	$110K	Buy	2,498 +531	+27%	+$23K	0.1%	293
2021 Q4	$84K	Sell	1,967 -11,574	-85%	-$486K	0.12%	235
2021 Q3	$475K	Buy	13,541 +486	+4%	+$21.5K	0.54%	57
2021 Q2	$558K	Buy	13,055 +8,321	+176%	+$350K	0.56%	48
2021 Q1	$183K	Buy	+4,734	New	+$179K	0.2%	169
2020 Q4	–	Sell	-17,085	Closed	-$652K	–	427
2020 Q3	$652K	Buy	17,085 +3,544	+26%	+$137K	0.66%	27
2020 Q2	$475K	Buy	13,541 +8,081	+148%	+$291K	0.54%	57
2020 Q1	$178K	Buy	+5,460	New	+$213K	0.29%	134
2019 Q4	–	Sell	-525	Closed	-$22K	–	273
2019 Q3	$22K	Buy	+525	New	+$22.2K	0.01%	255

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Neo Ivy Capital Management's BSX Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 14,236 shares — an estimated $893K sold.

Neo Ivy Capital Management first reported a position in BSX in Q3 2019 and held it in 11 quarters. The position peaked at $893K in Q1 2026. 1,484 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Neo Ivy Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Neo Ivy Capital Management sold 14,236 Boston Scientific shares in Q2 2026, an estimated $893K.
Neo Ivy Capital Management first reported a position in Boston Scientific in Q3 2019 and held it in 11 quarters.
Neo Ivy Capital Management's Boston Scientific position peaked at $893K in Q1 2026.
1,484 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.